Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Orally available sEH/PDE4 dual inhibitors

Orally available sEH/PDE4 dual inhibitors

US Patent 11572347 · Granted Feb 7, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for the prevention or treatment of cytokine storm2025
Treatment of neurodevelopmental disorders2025
Methods of inhibiting formation of alpha synuclein aggregates2025
Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) in2024
Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) in2024
Co-crystal of sorafenib derivatives and process for preparation thereof2024
Co-crystal of sorafenib derivatives and process for preparation thereof2024
Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (F2024
Methods of improving cell-based therapy2023
Methods of improving cell-based therapy2023
Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble2022
Methods of improving cancer chemotherapy2022